← All organizations

NeoImmuneTech, Inc.

For profitWebsite ↗

Also known as: NeoImmuneTech | NeoImmune Tech | NeoImmuneTech, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2010s

Jan 1, 2014
NeoImmuneTech, Inc.— Founded

Drugs by trial phase (14 distinct, 11 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT07200089CollaboratorPhase 1Jan 31, 2026
NCT07052305CollaboratorPhase 1Oct 31, 2025
NCT04984811Lead sponsorPhase 2Nov 3, 2021
NCT05075603Lead sponsorPhase 1Aug 6, 2021
NCT04588038CollaboratorPhase 1Mar 12, 2021
NCT04594811Lead sponsorPhase 2Jan 7, 2021
NCT04498325CollaboratorPhase 1Dec 31, 2020
NCT04501796Lead sponsorPhase 1Aug 31, 2020
NCT04332653Lead sponsorPhase 1/Phase 2Apr 15, 2020
NCT04054752CollaboratorPhase 1Aug 16, 2019
NCT03901573Lead sponsorPhase 1/Phase 2Jun 30, 2019
NCT03901573Study chairPhase 1/Phase 2Jun 30, 2019

Details

Founded: Seongnam, KR Jan 1, 2014
Last known activity: Jan 31, 2026